Immediate Impact
17 standout
Citing Papers
Hepatocellular carcinoma: signaling pathways and therapeutic advances
2025 Standout
Cancer stem cells and niches: challenges in immunotherapy resistance
2025 Standout
Works of Xuqi Sun being referenced
Reductions in AFP and PIVKA-II can predict the efficiency of anti-PD-1 immunotherapy in HCC patients
2021
Comparison of the Prognostic Value of Inflammation-Based Scores in Patients with Hepatocellular Carcinoma After Anti-PD-1 Therapy
2021
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Xuqi Sun | 183 | 108 | 69 | 73 | 27 | 263 | |
| Yizhen Fu | 201 | 101 | 92 | 75 | 37 | 334 | |
| Songqiang Zhou | 163 | 105 | 73 | 61 | 15 | 273 | |
| Yan‐Jun Xiang | 204 | 73 | 48 | 73 | 28 | 259 | |
| Shinsuke Uchikawa | 192 | 93 | 32 | 81 | 35 | 275 | |
| Ying Liu | 194 | 79 | 57 | 112 | 24 | 305 | |
| C. Gog | 180 | 179 | 87 | 44 | 26 | 333 | |
| Michinori Hamaoka | 182 | 133 | 75 | 73 | 36 | 273 | |
| Zili Hu | 120 | 95 | 62 | 59 | 34 | 279 | |
| Toshitaka Sugawara | 116 | 168 | 92 | 84 | 23 | 278 | |
| Fei Cao | 219 | 60 | 66 | 69 | 32 | 275 |
All Works
Login with ORCID to disown or claim papers
Loading papers...